SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is a key trending stock as the community eagerly awaits its upcoming earnings report, widely expected to show significant revenue recognition from its operational Polaris Forge 1 facility. Investors are highly optimistic about potential new hyperscaler contract announcements and the company's crucial position in the rapidly expanding AI data center infrastructure sector, fueling discussions of a substantial re-rating and short squeeze potential.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is actively trending amid discussions surrounding a crucial upcoming MSCI reclassification decision, which could trigger significant institutional fund outflows. The community is sharply divided, with bulls anticipating a rebound and a perceived discount to Bitcoin holdings, while bears emphasize ongoing share dilution and the potential impact of the index decision on its market value as a Bitcoin proxy.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid intense community discussion linking its advanced AI and data analytics platforms to recent significant geopolitical events, including a successful US mission in Venezuela. Bulls are speculating that its technology played a crucial role, fueling optimism for increased defense contracts and a potential rally. Conversely, many skeptics are highlighting the stock's high valuation and recent volatility, leading to a polarized debate on its immediate market direction.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to the operational Bridge integration, a Stripe-backed fiat anchor, which facilitates seamless on/off-ramps for major currencies and stablecoins. The community highlights Keeta's compliance-first, high-throughput Layer 1 infrastructure as a key differentiator, positioning it as a crucial solution for institutional settlement and cross-chain routing.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase Global is trending following a significant upgrade from Goldman Sachs, which has boosted positive sentiment within the community. The stock is also gaining momentum amid a broader cryptocurrency market rally, with many discussing Coinbase's strategic vision to become an "Everything Exchange" and its potential in stock perpetual futures. This confluence of institutional backing and future-focused initiatives is driving significant investor interest.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is experiencing significant market attention following geopolitical developments in Venezuela, which could unlock access to the nation's immense oil reserves. The community is actively discussing whether CVX, as a key operator in the region, is strategically positioned for substantial long-term benefits or if the current surge represents a short-term overreaction. Many view this as a pivotal event for the broader energy sector, prompting debate on its immediate and lasting impact on oil majors.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as reports circulate regarding escalating US geopolitical involvement in Venezuela, which many in the community view as a significant catalyst for safe-haven assets. Discussions are actively focused on gold's potential to rise amidst heightened global uncertainty and the broader implications for the dollar's standing.

GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

GH Research PLC

GH Research PLC is trending following the FDA's decision to lift the clinical hold on its GH001 program, enabling progress toward Phase 3 trials slated for 2026. The community exhibits a divided reaction, with some viewing this as a significant step forward for both the company and the broader psychedelic treatment sector, while others express concerns over the extended timeline for trial initiation. Further complicating sentiment is a recently priced public offering, which adds to the ongoing debate among investors.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to the recent completion of its Ask Sage acquisition, bolstering its secure generative AI offerings for defense and regulated sectors. The company also announced a significant debt reduction through converting convertible notes to equity, which the community views as a strategic move to strengthen its balance sheet and enhance contract credibility. Investors are keenly watching for anticipated major government contract announcements, despite some concerns about potential share dilution.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is actively trending as the community discusses potential opportunities stemming from recent geopolitical shifts involving Venezuela, which holds the world's largest oil reserves. There's significant anticipation that American oil majors, including XOM, could be poised to re-engage and invest in revitalizing Venezuela's energy infrastructure. This development is fueling bullish sentiment for energy stocks, with conversations balancing excitement about long-term value against debates over potential impacts on global oil supply and pricing dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbCellera Biologics (NASDAQ:ABCL) Cut to Sell at Wall Street Zen

Wall Street Zen lowered AbCellera Biologics from a "hold" rating to a "sell" rating in a research report on Sunday...

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of "Hold" by Analysts

Shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Get Free Report) have been given a consensus rating of "Hold" by the seven brokerages that are presently covering the stock, Marketbeat reports. One...

AbCellera Biologics (NASDAQ:ABCL) Upgraded at Wall Street Zen

Wall Street Zen upgraded AbCellera Biologics from a "sell" rating to a "hold" rating in a report on Saturday...

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

Norges Bank Makes New $2.16 Million Investment in AbCellera Biologics Inc. $ABCL

Norges Bank bought a new stake in AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission...

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. A live audio webcast of the presentation may be...

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera (Nasdaq: ABCL) today announced the appointment of Stephen Quake, D.Phil., to its Board of Directors as an independent director. Dr. Quake is a distinguished scientist, inventor, and...

AbCellera Biologics (NASDAQ:ABCL) Posts Quarterly Earnings Results

AbCellera Biologics (NASDAQ:ABCL - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus...

AbCellera Biologics (NASDAQ:ABCL) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of AbCellera Biologics from a "hold" rating to a "sell" rating in a research report on Saturday...

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - What's Next?

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - What's Next...

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

ABCL
AbCellera Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABCL News

ABCLAbCellera Biologics Inc